| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICE | Common Stock | Options Exercise | $583K | +11.7K | +7.46% | $50.01 | 168K | Nov 13, 2024 | Direct | F1, F2 |
| transaction | ICE | Common Stock | Sale | -$862K | -5.53K | -3.29% | $156.00 | 162K | Nov 13, 2024 | Direct | F1, F3 |
| transaction | ICE | Common Stock | Sale | -$961K | -6.13K | -3.78% | $156.83 | 156K | Nov 13, 2024 | Direct | F1, F4, F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICE | Employee Stock Option (right to buy) Holding | Options Exercise | $0 | -11.7K | -50% | $0.00 | 11.7K | Nov 13, 2024 | Common Stock | 11.7K | $50.01 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 14, 2024 |
| F2 | Amount of securities beneficially owned includes 98 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 28, 2024. |
| F3 | The price range for the aggregate amount sold by the direct holder is $155.55 - $156.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| F4 | The price range for the aggregate amount sold by the direct holder is $156.55 - $157.10. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| F5 | The common stock number referred in Table I is an aggregate number and represents 135,348 shares of common stock and 20,815 unvested performance based restricted stock units for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2024 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting. The satisfaction of the 2022, 2023 and 2024 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025, February 2026 and February 2027 respectively, and will be reported at the time of vesting. |
| F6 | The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. |
| F7 | These options are fully vested. |